Construction and Application of Testicular Organoid Models in Multi-Omics-Driven Male Reproductive Toxicity Assessment: A Review
International Journal of Molecular Sciences · 06.11.2026 · 27 (21) · 9963
DOI: 10.3390/ijms27219963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2026. Verfasst von Yuting Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Shandong Second Medical University, Weifang 261053, China. Hauptthemen laut MEDLINE: Organoids, Testis, Toxicity Tests, Reproduction. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shandong Provincial Natural Science Foundation, Shandong Provincial Natural Science Foundation, Project of China Association of Higher Education.
Abstract (Originalsprache)
Conventional male reproductive toxicity testing relies on rodent bioassays and two-dimensional cultures, which are limited by species extrapolation, low throughput, and weak mechanistic resolution. Testicular and seminiferous-tubule organoids partially restore the Sertoli–Leydig–peritubular myoid niche and permit serial, non-terminal sampling, making them compatible with multi-omics profiling in a way earlier models were not. This review examines the field across four layers: the biological hierarchy and regulatory pathways that constrain model design; organoid construction strategies together with computational simulation of morphogenesis and mass transport; multi-omics integration algorithms and toxicity feature extraction; and retrospective validation on publicly deposited datasets. We compare cell sourcing, scaffold, and culture configuration routes against tubule formation and meiotic completion, derive critical-radius and shear-stress criteria governing construct viability, and evaluate similarity network fusion, latent factor decomposition, joint matrix factorization, and graph neural network approaches. Retrospective modeling indicates that adding epigenomic input to transcriptomic features yields the largest performance gain, that gradient-boosted trees outperform deep networks at current sample sizes, and that attribution profiles align with established mechanisms. We contribute an integration framework dimensioned for testicular organoid data, a fully open-source reproducible pipeline, and an explicit mapping between quantitative organoid descriptors and toxicity endpoints. Persistent obstacles include incomplete structural reconstitution biasing omics signal, sparse and inconsistently annotated public data, simulation parameter uncertainty, and unverified cross-species transfer. Minimum reporting standards, a shared characterization vocabulary, and an open benchmark platform are proposed as prerequisites for regulatory uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Technology, Shandong Second Medical University, Weifang 261053, China.
Förderung
- the Shandong Provincial Natural Science Foundation
- Shandong Provincial Natural Science Foundation
- Project of China Association of Higher Education
Zitieren
APA
Sun, Y., Liu, Y., & Xie, M. (2026). Construction and Application of Testicular Organoid Models in Multi-Omics-Driven Male Reproductive Toxicity Assessment: A Review. International Journal of Molecular Sciences, 27(21), 9963. https://doi.org/10.3390/ijms27219963
Vancouver
Sun Y, Liu Y, Xie M. Construction and Application of Testicular Organoid Models in Multi-Omics-Driven Male Reproductive Toxicity Assessment: A Review. International Journal of Molecular Sciences. 2026;27(21):9963. doi:10.3390/ijms27219963
BibTeX
@article{Sun2026,
author = {Sun, Yuting and Liu, Yan and Xie, Meina},
title = {Construction and Application of Testicular Organoid Models in Multi-Omics-Driven Male Reproductive Toxicity Assessment: A Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9963},
doi = {10.3390/ijms27219963}
}
EUVIMED